Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

[1]  D. Ku,et al.  Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. , 1999, American journal of physiology. Heart and circulatory physiology.

[2]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[3]  M. Zile,et al.  Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function. , 1999, Circulation research.

[4]  K. Lehti,et al.  MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells , 1999, Hepatology.

[5]  J. McEwan,et al.  Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. , 1999, Circulation.

[6]  P. Libby,et al.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.

[7]  R. Greenwald.  Thirty‐six Years in the Clinic without an MMP Inhibitor: What Hath Collagenase Wrought? , 1999, Annals of the New York Academy of Sciences.

[8]  T. K. Hunt,et al.  Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. , 1999, The Journal of surgical research.

[9]  H. M. Lee,et al.  A Chemically Modified Nonantimicrobial Tetracycline (CMT‐8) Inhibits Gingival Matrix Metalloproteinases, Periodontal Breakdown, and Extra‐Oral Bone Loss in Ovariectomized Rats , 1999, Annals of the New York Academy of Sciences.

[10]  F. C. Nelson,et al.  Design and Synthetic Considerations of Matrix Metalloproteinase Inhibitors , 1999, Annals of the New York Academy of Sciences.

[11]  J. Woessner.  Matrix Metalloproteinase Inhibition: From The Jurassic To The Third Millennium , 1999, Annals of the New York Academy of Sciences.

[12]  J. Sipley,et al.  Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion* , 1999, The Journal of Biological Chemistry.

[13]  P. Carmeliet,et al.  Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice , 1999, Thrombosis and Haemostasis.

[14]  A. Feldman,et al.  Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. , 1999, Cardiovascular research.

[15]  J. Bishop,et al.  Regulation of cardiovascular collagen synthesis by mechanical load. , 1999, Cardiovascular research.

[16]  J. McEwan,et al.  TIMP-4 is regulated by vascular injury in rats. , 1999, Annals of the New York Academy of Sciences.

[17]  C. López-Otín,et al.  Induction of Collagenase-3 (MMP-13) Expression in Human Skin Fibroblasts by Three-dimensional Collagen Is Mediated by p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.

[18]  H. Emonard,et al.  Fibroblast-cytokine-extracellular matrix interactions in wound repair. , 1999, Current topics in pathology. Ergebnisse der Pathologie.

[19]  B. Duce,et al.  Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. , 1999, Journal of the American Society of Nephrology : JASN.

[20]  H. Larjava,et al.  MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? , 1998, Biochemical and biophysical research communications.

[21]  Jian-Dong Li,et al.  Tumor‐derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38 , 1998, FEBS letters.

[22]  D. Lovett,et al.  A Synergistic Interaction of Transcription Factors AP2 and YB-1 Regulates Gelatinase A Enhancer-dependent Transcription* , 1998, The Journal of Biological Chemistry.

[23]  M. Crow,et al.  Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. , 1998, Circulation.

[24]  P. Carmeliet,et al.  Reduced transplant arteriosclerosis in plasminogen-deficient mice. , 1998, The Journal of clinical investigation.

[25]  A. Baker,et al.  Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins , 1998, Gene Therapy.

[26]  Y. Sun,et al.  Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. , 1998, Circulation.

[27]  É. Allaire,et al.  Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.

[28]  F. Ramires,et al.  Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart , 1998 .

[29]  S. Tyagi,et al.  Stretch‐induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells , 1998, Journal of cellular physiology.

[30]  Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. , 1998, Hypertension.

[31]  H. Lijnen,et al.  Regulation of Gelatinase Activity in Mice with Targeted Inactivation of Components of the Plasminogen/Plasmin System , 1998, Thrombosis and Haemostasis.

[32]  F. Spinale,et al.  Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy , 1998 .

[33]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[34]  R. Fridman,et al.  High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV* , 1998, The Journal of Biological Chemistry.

[35]  A. Baker,et al.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.

[36]  Z. Galis,et al.  Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Minh N. H. Nguyen,et al.  Active and Tissue Inhibitor of Matrix Metalloproteinase-free Gelatinase B Accumulates within Human Microvascular Endothelial Vesicles* , 1998, The Journal of Biological Chemistry.

[38]  L. Matrisian,et al.  Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. , 1998, Molecular biology of the cell.

[39]  G. Murphy,et al.  Membrane-Type Matrix Metalloproteinases and Cell Surface-Associated Activation Cascades for Matrix Metalloproteinases , 1998 .

[40]  Thiennu H. Vu,et al.  Gelatinase B: Structure, Regulation, and Function , 1998 .

[41]  W. Stetler-Stevenson,et al.  72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity , 1998 .

[42]  K. Weber,et al.  Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.

[43]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[44]  G. Norton,et al.  Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. , 1997, Circulation.

[45]  I. Dixon,et al.  Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan. , 1997, Journal of molecular and cellular cardiology.

[46]  P. Soloway,et al.  Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. , 1997, Biology of reproduction.

[47]  S. Shapiro,et al.  Mighty mice: transgenic technology "knocks out" questions of matrix metalloproteinase function. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[48]  B. Toole,et al.  Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells* , 1997, The Journal of Biological Chemistry.

[49]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  J. Greene,et al.  Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4* , 1996, The Journal of Biological Chemistry.

[51]  A. Clowes,et al.  Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.

[52]  K. Weber,et al.  Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. , 1996, Hypertension.

[53]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[54]  J. Woessner,et al.  Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. , 1996, The American journal of pathology.

[55]  P. Atadja,et al.  Differential effects of transforming growth factor-β1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts , 1996, Experimental Gerontology.

[56]  A. A. Lee,et al.  Adenovirus-mediated overexpression of human transforming growth factor-beta 1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. , 1996, Journal of molecular and cellular cardiology.

[57]  J. S. Janicki,et al.  Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells , 1996, Journal of cellular physiology.

[58]  C. Brinckerhoff,et al.  Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. , 1996, Critical reviews in eukaryotic gene expression.

[59]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[60]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[61]  K. Weber,et al.  Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.

[62]  P. Whittaker.  Unravelling the mysteries of collagen and cicatrix after myocardial infarction. , 1995, Cardiovascular research.

[63]  H. Kleinman,et al.  Laminin SIKVAV Peptide Induction of Monocyte/Macrophage Prostaglandin E and Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.

[64]  Z. Werb,et al.  Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin , 1995, The Journal of cell biology.

[65]  M. J. López-Zabalza,et al.  Activation of human lymphomononuclear cells by peptides derived from extracellular matrix proteins. , 1995, Biochimica et biophysica acta.

[66]  H. Guo,et al.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.

[67]  W. Hornebeck,et al.  Growth stimulation of human skin fibroblasts by elastin-derived peptides. , 1995, Cell adhesion and communication.

[68]  J S Janicki,et al.  Ventricular remodeling in heart failure: the role of myocardial collagen. , 1995, Advances in experimental medicine and biology.

[69]  Mark D. Johnson,et al.  Inhibition of angiogenesis by tissue inhibitor of metalloproteinase , 1994, Journal of cellular physiology.

[70]  Z. Werb,et al.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.

[71]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[72]  E. Sage,et al.  The biology of SPARC, a protein that modulates cell‐matrix interactions , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  C A Beltrami,et al.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.

[74]  S. Wahl,et al.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Jimenez,et al.  Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. , 1993, The Journal of biological chemistry.

[76]  W. Stetler-Stevenson,et al.  Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1993, Biochemistry.

[77]  J. S. Janicki,et al.  Myocardial collagen and its functional role. , 1993, Advances in experimental medicine and biology.

[78]  C. Brinckerhoff,et al.  Post‐Transcriptional regulationa of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts , 1992 .

[79]  P. Quax,et al.  Cultured rat aortic vascular smooth muscle cells digest naturally produced extracellular matrix. Involvement of plasminogen-dependent and plasminogen-independent pathways. , 1992, Circulation research.

[80]  A. Eisen,et al.  Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.

[81]  D. Mukherjee,et al.  Alteration of collagen phenotypes in ischemic cardiomyopathy. , 1991, The Journal of clinical investigation.

[82]  V. Lefebvre,et al.  Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. , 1991, Biochimica et biophysica acta.

[83]  M. Eghbali,et al.  Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. , 1991, Circulation research.

[84]  D. Auble,et al.  The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. , 1991, Biochemistry.

[85]  M. Yacoub,et al.  Enhanced deposition of predominantly type I collagen in myocardial disease. , 1990, Journal of molecular and cellular cardiology.

[86]  M. Eghbali,et al.  Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. , 1990, Circulation research.

[87]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[88]  B. Wasylyk,et al.  The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites. , 1990, The EMBO journal.

[89]  K. Weber,et al.  Cardiac interstitium in health and disease: the fibrillar collagen network. , 1989, Journal of the American College of Cardiology.

[90]  D. Brenner,et al.  Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.

[91]  S. Krane,et al.  Increases in levels of procollagenase mRNA in human fibroblasts induced by interleukin-1, tumor necrosis factor-alpha, or serum follow c-jun expression and are dependent on new protein synthesis. , 1989, Transactions of the Association of American Physicians.

[92]  Michael E. Greenberg,et al.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities , 1988, Cell.

[93]  F. Maquart,et al.  Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+ , 1988, FEBS letters.

[94]  S. Shroff,et al.  Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate Myocardium , 1988, Circulation research.